# Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

> **NCT02015650** · PHASE4 · TERMINATED · sponsor: **Medical University Innsbruck** · enrollment: 4 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Mitomycin-C/ 5-Fluorouracil

## Key facts

- **NCT ID:** NCT02015650
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2016-04-19
- **Final completion:** 2016-04-19
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low Recruitment rate
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015650, "Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02015650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*